Compare Ares Capital Corporation (ARCC) vs Figs Inc (FIGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ares Capital Corporation vs Figs Inc — how do they compare? Ares Capital Corporation trades at $18.78 (market cap $13.48B), while Figs Inc trades at $10.24 (market cap $1.68B). The key difference: Ares Capital Corporation is far larger — about 8× Figs Inc's market cap, and Ares Capital Corporation pays a 10.22% dividend while Figs Inc pays none. Which is the better fit depends on your goals.
| ARCC | FIGS | |
|---|---|---|
Market Cap | $13.48B | $1.68B |
Sector | Financials | Consumer Cyclical |
52-Week High | $23.25 | $17.12 |
52-Week Low | $17.45 | $5.81 |
Dividend Yield | 10.22% | — |
Enterprise Value | — | $1.46B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ares Capital (ARCC) trades at $18.78, up 2.01% on the day, with a bearish technical signal but strong analyst support. The stock shows a P/E of 11.52 and P/B of 0.96, trading below the consensus price target of $20.58. Recent earnings have missed expectations, with Q2 2026 results pending, while revenue declined to $1.51B in 2025 from $1.7B in 2024. A dividend of $0.48 is scheduled for payment on June 30, 2026, supporting income appeal amid mixed sentiment.
ARCC presents a value opportunity with a high dividend yield and undervaluation relative to analyst targets, but faces headwinds from earnings misses and a bearish technical outlook. Risks include revenue volatility and competitive pressures in the BDC space, though institutional buy ratings suggest confidence in recovery potential. Investors should weigh income stability against growth challenges.
FIGS trades at $10.04, down 2.81% today, with a bearish technical signal from moving averages despite recent earnings beats. Revenue grew to $631.10M in 2025 with a 66.61% gross margin, but net cash flow remains negative. Analyst consensus is Buy with a $18.00 price target, suggesting significant upside from current levels.
The stock offers growth potential through healthcare apparel demand and global expansion, but faces risks from valuation multiples (P/E 45.64), margin pressures, and persistent negative cash flow. Investor sentiment is mixed amid cost headwinds and competitive dynamics in the apparel sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
Read more on ARCC →About Figs Inc
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →
